Nob Hill Therapeutics (NHT) is pleased to announce that it has successfully raised $3,000,000 in a recent funding round, propelling the company closer to achieving its mission of revolutionizing inhalation therapy. NHT is at the forefront of innovation with its first-of-its-kind dry powder nebulizer, the DryNeb™, a groundbreaking inhalation drug delivery platform aimed at effectively treating lower respiratory tract infections—currently ranked as the fifth leading cause of death worldwide, along with other life-threatening lung diseases. This fresh influx of capital will be instrumental in advancing the clinical development of DryNeb™ and accelerating its pathway to market. The funding will support crucial phases of research and development, including extensive testing to ensure the device's efficacy and safety. Furthermore, it will enable NHT to enhance its manufacturing capabilities and distribution network, ensuring that this vital technology is accessible to patients in need. As the demand for effective inhalation therapies grows, Nob Hill Therapeutics stands poised to make a significant impact on global health outcomes, specifically targeting communities affected by severe respiratory conditions. The company is excited about the journey ahead and grateful to its investors for their confidence in its vision to bring transformative solutions to patients struggling with respiratory ailments. With this funding announcement, Nob Hill Therapeutics reaffirms its commitment to improving lives through innovative healthcare technology and addressing some of the most pressing health challenges of our time.
Nob Hill Therapeutics Secures $3 Million in Series A Funding for Revolutionary Inhalation Drug Delivery Platform
Recently funded · $3.0M Series aHealthcare
Get the full Nob Hill Therapeutics company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Aligned Marketplace | Series a | $20.0M | today |
| 2 |  Vals AI United States | Series a | $40.0M | today |
| 3 |
.png&w=3840&q=75)
